Literature DB >> 19651612

Inclusion formation and neuronal cell death through neuron-to-neuron transmission of alpha-synuclein.

Paula Desplats1, He-Jin Lee, Eun-Jin Bae, Christina Patrick, Edward Rockenstein, Leslie Crews, Brian Spencer, Eliezer Masliah, Seung-Jae Lee.   

Abstract

Neuronal accumulation of alpha-synuclein and Lewy body formation are characteristic to many neurodegenerative diseases, including Parkinson's disease (PD). This Lewy pathology appears to spread throughout the brain as the disease progresses. Furthermore, recent studies showed the occurrence of Lewy pathology in neurons grafted into the brains of PD patients, suggesting the spread of pathology from the host tissues to the grafts. The mechanism underlying this propagation is unknown. Here, we show that alpha-synuclein is transmitted via endocytosis to neighboring neurons and neuronal precursor cells, forming Lewy-like inclusions. Moreover, alpha-synuclein was transmitted from the affected neurons to engrafted neuronal precursor cells in a transgenic model of PD-like pathology. Failure of the protein quality control systems, especially lysosomes, promoted the accumulation of transmitted alpha-synuclein and inclusion formation. Cells exposed to neuron-derived alpha-synuclein showed signs of apoptosis, such as nuclear fragmentation and caspase 3 activation, both in vitro and in vivo. These findings demonstrate the cell-to-cell transmission of alpha-synuclein aggregates and provide critical insights into the mechanism of pathological progression in PD and other proteinopathies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651612      PMCID: PMC2722313          DOI: 10.1073/pnas.0903691106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

Review 1.  Transmissible spongiform encephalopathies, amyloidoses and yeast prions: common threads?

Authors:  B Caughey
Journal:  Nat Med       Date:  2000-07       Impact factor: 53.440

2.  Formation and removal of alpha-synuclein aggregates in cells exposed to mitochondrial inhibitors.

Authors:  He-Jin Lee; Soon Young Shin; Chan Choi; Young Han Lee; Seung-Jae Lee
Journal:  J Biol Chem       Date:  2001-11-27       Impact factor: 5.157

Review 3.  The role of alpha-synuclein in Parkinson's disease: insights from animal models.

Authors:  Eleonora Maries; Biplob Dass; Timothy J Collier; Jeffrey H Kordower; Kathy Steece-Collier
Journal:  Nat Rev Neurosci       Date:  2003-09       Impact factor: 34.870

4.  Staging of brain pathology related to sporadic Parkinson's disease.

Authors:  Heiko Braak; Kelly Del Tredici; Udo Rüb; Rob A I de Vos; Ernst N H Jansen Steur; Eva Braak
Journal:  Neurobiol Aging       Date:  2003 Mar-Apr       Impact factor: 4.673

Review 5.  Parkinson's disease: mechanisms and models.

Authors:  William Dauer; Serge Przedborski
Journal:  Neuron       Date:  2003-09-11       Impact factor: 17.173

Review 6.  Molecular pathways of neurodegeneration in Parkinson's disease.

Authors:  Ted M Dawson; Valina L Dawson
Journal:  Science       Date:  2003-10-31       Impact factor: 47.728

7.  Propagation of tau misfolding from the outside to the inside of a cell.

Authors:  Bess Frost; Rachel L Jacks; Marc I Diamond
Journal:  J Biol Chem       Date:  2009-03-11       Impact factor: 5.157

8.  Differential neuropathological alterations in transgenic mice expressing alpha-synuclein from the platelet-derived growth factor and Thy-1 promoters.

Authors:  Edward Rockenstein; Margaret Mallory; Makoto Hashimoto; David Song; Clifford W Shults; Ingrid Lang; Eliezer Masliah
Journal:  J Neurosci Res       Date:  2002-06-01       Impact factor: 4.164

Review 9.  The neuropathogenic contributions of lysosomal dysfunction.

Authors:  Ben A Bahr; Jennifer Bendiske
Journal:  J Neurochem       Date:  2002-11       Impact factor: 5.372

10.  Neuronal accumulation of alpha- and beta-synucleins in the brain of a GM2 gangliosidosis mouse model.

Authors:  Kyoko Suzuki; Eizo Iseki; Omi Katsuse; Akira Yamaguchi; Kayoko Katsuyama; Ichiro Aoki; Shoji Yamanaka; Kenji Kosaka
Journal:  Neuroreport       Date:  2003-03-24       Impact factor: 1.837

View more
  682 in total

1.  Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization.

Authors:  Judith Eschbach; Björn von Einem; Kathrin Müller; Hanna Bayer; Annika Scheffold; Bradley E Morrison; K Lenhard Rudolph; Dietmar R Thal; Anke Witting; Patrick Weydt; Markus Otto; Michael Fauler; Birgit Liss; Pamela J McLean; Albert R La Spada; Albert C Ludolph; Jochen H Weishaupt; Karin M Danzer
Journal:  Ann Neurol       Date:  2014-12-19       Impact factor: 10.422

2.  ATP13A2/PARK9 regulates secretion of exosomes and α-synuclein.

Authors:  Taiji Tsunemi; Kana Hamada; Dimitri Krainc
Journal:  J Neurosci       Date:  2014-11-12       Impact factor: 6.167

Review 3.  Recent advances in the genetics of Parkinson's disease.

Authors:  Ian Martin; Valina L Dawson; Ted M Dawson
Journal:  Annu Rev Genomics Hum Genet       Date:  2011       Impact factor: 8.929

Review 4.  Intercellular (mis)communication in neurodegenerative disease.

Authors:  Gwenn A Garden; Albert R La Spada
Journal:  Neuron       Date:  2012-03-08       Impact factor: 17.173

5.  Mitochondrial permeability transition pore regulates Parkinson's disease development in mutant α-synuclein transgenic mice.

Authors:  Lee J Martin; Samantha Semenkow; Allison Hanaford; Margaret Wong
Journal:  Neurobiol Aging       Date:  2013-11-16       Impact factor: 4.673

6.  Relationship of neighboring tissue and gliosis to α-synuclein pathology in a fetal transplant for Parkinson's disease.

Authors:  Tae-Beom Ahn; J William Langston; Venkat Raghav Aachi; Dennis W Dickson
Journal:  Am J Neurodegener Dis       Date:  2012-04-18

7.  Exosomes-associated neurodegeneration and progression of Parkinson's disease.

Authors:  Isabella Russo; Luigi Bubacco; Elisa Greggio
Journal:  Am J Neurodegener Dis       Date:  2012-11-18

Review 8.  Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

Review 9.  Autophagy in Parkinson's Disease.

Authors:  Xu Hou; Jens O Watzlawik; Fabienne C Fiesel; Wolfdieter Springer
Journal:  J Mol Biol       Date:  2020-02-13       Impact factor: 5.469

10.  Next-generation active immunization approach for synucleinopathies: implications for Parkinson's disease clinical trials.

Authors:  Markus Mandler; Elvira Valera; Edward Rockenstein; Harald Weninger; Christina Patrick; Anthony Adame; Radmila Santic; Stefanie Meindl; Benjamin Vigl; Oskar Smrzka; Achim Schneeberger; Frank Mattner; Eliezer Masliah
Journal:  Acta Neuropathol       Date:  2014-02-14       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.